InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Entrada Therapeutics, Inc.

TRDA Clue Score28
United States Fiscal year ends December CIK 0001689375 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

62
Insider
Date
Role
Action
Shares
Price
Amount
Natarajan Sethuraman
4 May 2026
President, Research & Develop.
Sold on a plan
25,907
$15.39
$398.81K
Kory James Wentworth
1 Apr 2026
Chief Financial Officer
Sold on a plan
2,500
$12.95
$32.38K
Kory James Wentworth
10 Mar 2026
Chief Financial Officer
Sold on a plan
11,388
$13.02
$148.22K
Nathan J Dowden
10 Mar 2026
President & COO
Sold on a plan
11,894
$13.05
$155.19K
Kory James Wentworth
9 Mar 2026
Chief Financial Officer
Sold on a plan
5,089
$13.00
$66.16K
Nathan J Dowden
9 Mar 2026
President & COO
Sold on a plan
3,116
$13.02
$40.58K
Kory James Wentworth
4 Mar 2026
Chief Financial Officer
Sold on a plan
7,988
$12.25
$97.89K
Kory James Wentworth
21 Nov 2025
Chief Financial Officer
Sold on a plan
8,910
$9.98
$88.93K
Kory James Wentworth
17 Mar 2025
Chief Financial Officer
Sold on a plan
1,784
$10.67
$19.04K
Natarajan Sethuraman
3 Dec 2024
President, Research & Develop.
Sold on a plan
11,703
$20.15
$235.79K
Natarajan Sethuraman
2 Dec 2024
President, Research & Develop.
Sold on a plan
4,088
$20.26
$82.83K
Natarajan Sethuraman
29 Nov 2024
President, Research & Develop.
Sold on a plan
100
$20.00
$2.00K
Natarajan Sethuraman
13 Nov 2024
President, Research & Develop.
Sold on a plan
2,700
$20.04
$54.11K
Natarajan Sethuraman
11 Nov 2024
President, Research & Develop.
Sold on a plan
1,409
$20.01
$28.19K
Natarajan Sethuraman
6 Nov 2024
President, Research & Develop.
Sold on a plan
2,745
$19.32
$53.02K
Natarajan Sethuraman
6 Nov 2024
President, Research & Develop.
Sold on a plan
9,554
$18.71
$178.75K
Natarajan Sethuraman
5 Nov 2024
President, Research & Develop.
Sold on a plan
5,171
$18.18
$94.01K
Natarajan Sethuraman
4 Nov 2024
President, Research & Develop.
Sold on a plan
749
$18.02
$13.50K
Natarajan Sethuraman
16 Oct 2024
President, Research & Develop.
Sold on a plan
600
$18.00
$10.80K
Nathan J Dowden
26 Sep 2024
President & COO
Sold on a plan
847
$16.00
$13.55K
Natarajan Sethuraman
9 Sep 2024
Chief Scientific Officer
Sold on a plan
2,642
$15.09
$39.86K
Nathan J Dowden
9 Sep 2024
President & COO
Sold on a plan
1,904
$15.07
$28.69K
Kory James Wentworth
9 Sep 2024
Chief Financial Officer
Sold on a plan
3,195
$14.97
$47.83K
Natarajan Sethuraman
6 Sep 2024
Chief Scientific Officer
Sold on a plan
600
$15.24
$9.14K
Nathan J Dowden
6 Sep 2024
President & COO
Sold on a plan
399
$15.19
$6.06K
Dipal Doshi
15 Jul 2024
CEO
Sold on a plan
1,600
$17.81
$28.50K
Natarajan Sethuraman
15 Jul 2024
Chief Scientific Officer
Sold on a plan
638
$18.00
$11.48K
Dipal Doshi
12 Jul 2024
CEO
Sold on a plan
300
$18.00
$5.40K
Natarajan Sethuraman
12 Jul 2024
Chief Scientific Officer
Sold on a plan
600
$18.00
$10.80K
Kory James Wentworth
8 Jul 2024
Chief Financial Officer
Sold on a plan
1,758
$14.95
$26.28K
Dipal Doshi
13 Jun 2024
CEO
Sold on a plan
1,000
$16.17
$16.17K
Natarajan Sethuraman
20 May 2024
Chief Scientific Officer
Sold on a plan
9,675
$15.19
$146.94K
Dipal Doshi
17 May 2024
CEO
Sold on a plan
1,200
$15.11
$18.13K
Natarajan Sethuraman
17 May 2024
Chief Scientific Officer
Sold on a plan
8,305
$15.14
$125.75K
Dipal Doshi
16 May 2024
CEO
Sold on a plan
1,800
$15.00
$27.00K
Natarajan Sethuraman
16 May 2024
Chief Scientific Officer
Sold on a plan
1,000
$15.00
$15.00K
Nathan J Dowden
6 Mar 2024
President & COO
Sold on a plan
1,826
$12.32
$22.50K
Kory James Wentworth
6 Mar 2024
Chief Financial Officer
Sold on a plan
4,086
$12.31
$50.29K
Dipal Doshi
15 Feb 2024
CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
16 Jan 2024
CEO
Sold on a plan
1,000
$15.99
$15.99K
Dipal Doshi
20 Dec 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
13 Nov 2023
President and CEO
Sold on a plan
1,000
$16.23
$16.23K
Dipal Doshi
17 Oct 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Dipal Doshi
13 Sep 2023
President and CEO
Sold on a plan
1,000
$15.00
$15.00K
Nathan J Dowden
6 Sep 2023
Chief Operating Officer
Sold on a plan
59
$14.01
$826.41
Nathan J Dowden
6 Sep 2023
Chief Operating Officer
Sold on a plan
913
$13.43
$12.26K
Nerissa Kreher
6 Sep 2023
Chief Medical Officer
Sold on a plan
21
$14.00
$294.00
Nerissa Kreher
6 Sep 2023
Chief Medical Officer
Sold on a plan
871
$13.46
$11.73K
Kory James Wentworth
6 Sep 2023
Chief Financial Officer
Sold on a plan
46
$14.03
$645.38
Kory James Wentworth
6 Sep 2023
Chief Financial Officer
Sold on a plan
904
$13.45
$12.16K
Dipal Doshi
14 Aug 2023
President and CEO
Sold on a plan
1,000
$15.67
$15.67K
Natarajan Sethuraman
11 Jul 2023
Chief Scientific Officer
Sold on a plan
14,852
$18.04
$267.92K
Nathan J Dowden
11 Jul 2023
Chief Operating Officer
Sold on a plan
3,897
$18.05
$70.33K
Natarajan Sethuraman
10 Jul 2023
Chief Scientific Officer
Sold on a plan
3,026
$18.00
$54.47K
Nathan J Dowden
10 Jul 2023
Chief Operating Officer
Sold on a plan
3,200
$18.00
$57.61K
Nathan J Dowden
22 Jun 2023
Chief Operating Officer
Sold on a plan
7,097
$16.02
$113.70K
Nathan J Dowden
20 Jun 2023
Chief Operating Officer
Sold on a plan
8,885
$14.94
$132.70K
Dipal Doshi
27 Apr 2023
President and CEO
Sold on a plan
2,000
$13.71
$27.42K
Natarajan Sethuraman
17 Apr 2023
Chief Scientific Officer
Sold on a plan
3,961
$18.00
$71.32K
Dipal Doshi
17 Apr 2023
President and CEO
Sold on a plan
2,092
$18.01
$37.68K
Dipal Doshi
27 Mar 2023
President and CEO
Sold on a plan
200
$15.51
$3.10K
Dipal Doshi
27 Mar 2023
President and CEO
Sold on a plan
1,800
$14.63
$26.33K
Showing 250 of 282 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 215
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 26
Sales on a Rule 10b5-1 plan 62
Sales straight out of an exercise 45
Sales at will 110
Transactions with no price 0
Shares from compensation/vesting 26,064,466
Sales filed before the plan box existed 55
History held since 1 Nov 2021